This company listing is no longer active
Cell MedX Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Información clave
11.3%
Tasa de crecimiento de los beneficios
23.3%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | 4.3% |
| Tasa de crecimiento de los ingresos | 28.5% |
| Rentabilidad financiera | n/a |
| Margen neto | -37,440.5% |
| Última actualización de beneficios | 28 Feb 2022 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Cell MedX. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 28 Feb 22 | 0 | -1 | 1 | 0 |
| 30 Nov 21 | 0 | -1 | 1 | 0 |
| 31 Aug 21 | 0 | -1 | 1 | 0 |
| 31 May 21 | 0 | -1 | 0 | 0 |
| 28 Feb 21 | 0 | -1 | 1 | 0 |
| 30 Nov 20 | 0 | -1 | 1 | 0 |
| 31 Aug 20 | 0 | -1 | 1 | 0 |
| 31 May 20 | 0 | -1 | 1 | 0 |
| 29 Feb 20 | 0 | -1 | 1 | 0 |
| 30 Nov 19 | 0 | -1 | 1 | 0 |
| 31 Aug 19 | 0 | -1 | 1 | 0 |
| 31 May 19 | 0 | -1 | 0 | 0 |
| 28 Feb 19 | 0 | -1 | 0 | 0 |
| 30 Nov 18 | 0 | -1 | 0 | 1 |
| 31 Aug 18 | 0 | -1 | 0 | 1 |
| 31 May 18 | 0 | -2 | 1 | 0 |
| 28 Feb 18 | 0 | -1 | 1 | 0 |
| 30 Nov 17 | 0 | -1 | 1 | 0 |
| 31 Aug 17 | 0 | -2 | 1 | 0 |
| 31 May 17 | 0 | -1 | 1 | 0 |
| 28 Feb 17 | 0 | -2 | 1 | 0 |
| 30 Nov 16 | 0 | -2 | 1 | 0 |
| 31 Aug 16 | 0 | -1 | 1 | 0 |
| 31 May 16 | 0 | -2 | 1 | 1 |
| 29 Feb 16 | 0 | -2 | 1 | 1 |
| 30 Nov 15 | 0 | -2 | 1 | 1 |
Ingresos de calidad: 9CX is currently unprofitable.
Margen de beneficios creciente: 9CX is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: 9CX is unprofitable, but has reduced losses over the past 5 years at a rate of 11.3% per year.
Acelerando crecimiento: Unable to compare 9CX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: 9CX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-37.2%).
Rentabilidad financiera
Alta ROE: 9CX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.